Extrahepatic metastases occur in a minority of hepatocellular carcinoma patients treated with locoregional therapies: Analyzing patterns of progression in 285 patients
Seanthan Senthilnathan(Northwestern University), Riad Salem(Northwestern University), Khairuddin Memon(Northwestern University), Robert J. Lewandowski(Society of Interventional Radiology), Mary F. Mulcahy(Northwestern University), Paul Nikolaidis(Northwestern University), Reed A. Omary(Vanderbilt University), Talia Baker(University of Utah), Vahid Yaghmai(Virginia Commonwealth University Medical Center), Ahsun Riaz(Northwestern University), Frank H. Miller(Northwestern University), Laura Kulik(Northwestern University), Edward Wang, Michaël Abécassis(University of Arizona), Al B. Benson(Northwestern University)
Cited by 75
Related Papers
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k
Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors
|New England Journal of Medicine|2017|3.2k
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
|Journal of Clinical Oncology|2007|2.3k
Hepatobiliary Cancers
|Journal of the National Comprehensive Cancer Network|2009|2.3k